-
EP2924034
European procedure
Extract from the Register of European Patents
EP About this file: EP2924034
| EP2924034 - PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.09.2017 Database last updated on 08.04.2026 | Most recent event Tooltip | 01.12.2017 | Lapse of the patent in a contracting state New state(s): MC | published on 03.01.2018 [2018/01] | Applicant(s) | For all designated states Merck Canada Inc. 16711 Trans-Canada Highway Kirkland QC H9H 3L1 / CA | [2015/40] | Inventor(s) | 01 /
Burch, Jason 2645 Brewster Avenue Redwood City, CA California 94062 / US | 02 /
Cote, Bernard 113 Lucien Theriault Notre-Dame-de-l'll-Perrot, Québec J7V 7P2 / CA | [2015/40] | Representative(s) | Jaap, David Robert Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | [N/P] |
| Former [2015/40] | Jaap, David Robert Merck & Co., Inc. Patent Department Hertford Road Hoddesdon, Herts EN11 9BU / GB | Application number, filing date | 15157348.2 | 28.03.2011 | [2015/40] | Priority number, date | US20100318824P | 30.03.2010 Original published format: US 318824 P | US20100321573P | 07.04.2010 Original published format: US 321573 P | [2015/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2924034 | Date: | 30.09.2015 | Language: | EN | [2015/40] | Type: | B1 Patent specification | No.: | EP2924034 | Date: | 02.11.2016 | Language: | EN | [2016/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.06.2015 | Classification | IPC: | C07D401/06, A61K31/4439, A61P31/18 | [2015/40] | CPC: |
C07D401/06 (EP,KR,US);
A61K31/4439 (EP,KR,US);
A61K45/06 (EP,US);
A61P31/00 (EP);
A61P31/18 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/19] |
| Former [2015/40] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 30.03.2016 | ME | 30.03.2016 | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM NICHTNUKLEOSIDISCHEN REVERSE-TRANSKRIPTASEHEMMER | [2015/40] | English: | PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR | [2015/40] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR NON NUCLÉOSIDIQUE DE TRANSCRIPTASE INVERSE | [2015/40] | Examination procedure | 30.03.2016 | Examination requested [2016/19] | 27.05.2016 | Communication of intention to grant the patent | 19.09.2016 | Fee for grant paid | 19.09.2016 | Fee for publishing/printing paid | 19.09.2016 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11761856.1 / EP2552902 | Opposition(s) | 03.08.2017 | No opposition filed within time limit [2017/41] | Fees paid | Renewal fee | 03.07.2015 | Renewal fee patent year 03 | 03.07.2015 | Renewal fee patent year 04 | 19.06.2015 | Renewal fee patent year 05 | 08.03.2016 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 02.11.2016 | SM | 02.11.2016 | [2018/01] |
| Former [2017/45] | SM | 02.11.2016 | Documents cited: | Search | [A] WO2009067166 (MERCK & CO INC et al.) | [A] WO2004085411 (HOFFMANN LA ROCHE et al.) | [A] SWEENEY Z K ET AL: "Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 15, 1 August 2008 (2008-08-01), pages 4348 - 4351, XP023180554, ISSN: 0960-894X, [retrieved on 20080628], DOI: 10.1016/J.BMCL.2008.06.080 DOI: http://dx.doi.org/10.1016/j.bmcl.2008.06.080 | [A] CIHLAR T ET AL: "Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 85, no. 1, 1 January 2010 (2010-01-01), pages 39 - 58, XP026835803, ISSN: 0166-3542, [retrieved on 20091101] | [A] DE BETHUNE ET AL: "Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (19892009)", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 85, no. 1, 1 January 2010 (2010-01-01), pages 75 - 90, XP026835805, ISSN: 0166-3542, [retrieved on 20090923] | by applicant | WO0134578 | WO2004085406 | US7189718 | WO2005102989 | US7166738 | WO2006067587 | WO2007045572 | WO2007045573 | WO2008076225 | WO2009067166 | US2004192704 | US2007021442 | WO2007015812 | CLEMO ET AL.: "discloses certain derivatives of the 4-oxo-3-(2-pyridyl)pyridocoline system and in particular discloses 6-methyl-6'-phenoxy-2,2'-methylenedipyridine", J. CHERN. SOC., 1954, pages 2693 - 2702 | SWEENEY ET AL.: "discloses a series of triazolinones that were found to be non-nucleoside inhibitors of HIV reverse transcriptase", BIOORGANIC & MEDICINAL CHERN. LETTERS, vol. 18, 2008, pages 4348 - 4351 | "Design of Prodrugs", 1985, ELSEVIER | J. J. HALE ET AL., J. MED. CHEM., vol. 43, 2000, pages 1234 - 1241 | C. S. LARSEN; J. OSTERGAARD: "Textbook of Drug Design and Discovery", 2002, article "Design and application of prodrugs", pages: 410 - 458 | BEAUMONT ET AL., CURRENT DRUG METABOLISM, vol. 4, 2003, pages 461 - 458 | "Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING CO. | "Remington - The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS | "Physicians' Desk Reference", 2009 | KONNO ET AL., HETEROCYCLES, vol. 24, 1986, pages 2169 | COWDEN, C. J.; WILSON, R. D.; BISHOP, B. C.; COTTRELL, I. F.; DAVIES, A. J.; DOLLING, U.-H., TETRAHEDRON LETT., vol. 41, 2000, pages 8661 | CAN. J. CHEM., vol. 29, 1951, pages 478 | SHAW-REID ET AL., J. BIOL. CHEM., vol. 278, pages 2777 - 2780 | VACCA, J.P. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 4096 |